ReviewDrug design, development and therapy2026
Perioperative EGFR-Targeted Therapy in Resectable EGFR-Mutated NSCLC: A Narrative Review from Drug Design to Pain-Informed MRD-Guided Care.
Lile Xiong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.